Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum MTL Cannabis Corp C.MTLC

Alternate Symbol(s):  MTLNF

MTL Cannabis Corp. is focused on crafting cannabis products, including lines of dried flower, pre-rolls and hash marketed. The Company, through its subsidiaries, is engaged in the cultivation and production of cannabis products for recreational and medical purposes in Canada. It also operates clinics that work directly with primary care teams to provide specialized cannabinoid therapy services... see more

CSE:MTLC - Post Discussion

MTL Cannabis Corp > 2020 outlook !
View:
Post by letsflythis on Dec 29, 2020 6:55am

2020 outlook !

(1) Under the current supply agreement, Pharmadrug will sponsor Abba Medix for the receipt of its EU-GMP certification. Product shipments are expected to begin as early as March 31, 2020. (FAILURE) (2) Abba Medix has a 22,000 SF fully built out production facility (LIE), with a cultivation , processing and sales license in place, currently producing ~3,000 Kg p.a. of flower & trim (FAILURE) (3) has entered into a supply agreement with Alberta Gaming, Liquor and Cannabis ("AGLC") for the supply of branded cannabis products to the adult-use market in the Province of Alberta. Under the supply agreement, Abba will initially offer recreational use products in 3.5-gram dried flower and 0.5-gram pre-rolled formats. Abba continues to be engaged in advanced discussions with other provincial cannabis distribution branches as it executes its domestic distribution strategy. (FAILURE) (4) In 2019, Canada House focused on making its clinic division, Canada House Clinics ("CHC"), profitable (LIE), completing its production facility in Pickering (LIE), Ontario, substantially completing preparations towards EU-GMP certification (FAILURE), pursued provincial distribution agreements, and entered into two new international supply agreements. In 2020, the Company's strategy will be laser-focused on sustainable profitability and positive cash generation (LIE) by reducing expenses wherever possible, (CHRISS SALARY) pursuing opportunities with the highest ROI. The Company will continue to reduce non-core overhead, (CHRISS SALARY) close unprofitable clinics, and maintain continuous improvement initiatives across the entire organization. Canada House's specific efforts are described in more detail below.
Comment by LONAMIS777 on Dec 29, 2020 10:20am
"letsflythis - (12/29/2020 6:55:14 AM) 2020 outlook ! (1) Under the current supply agreement, Pharmadrug will sponsor Abba Medix for the receipt of its EU-GMP certification. Product shipments are expected to begin as early as March 31, 2020. (FAILURE) (2) Abba Medix has a 22,000 SF fully built out production facility (LIE), with a cultivation , processing and sales ...more  
Comment by letsflythis on Dec 29, 2020 11:56am
the reality hurts I know lonamis777 :)
Comment by LONAMIS777 on Dec 30, 2020 11:35am
"letsflythis - (12/29/2020 11:56:48 AM) RE:RE:2020 outlook ! the reality hurts I know lonamis777 :)" Haha, yeah, can't argue with that... :) GSTA THE LONGS
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities